Cubist Systematic Strategies’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Cubist Systematic Strategies’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-48,756	Closed	-$8.92K	–	4221
2023 Q2	$8.92K	Buy	+48,756	New	+$46.7K	﹤0.01%	3269
2021 Q3	–	Sell	-340	Closed	-$14K	–	3297
2021 Q2	$14K	Sell	340 -1,045	-75%	-$53.5K	﹤0.01%	2855
2021 Q1	$91K	Buy	+1,385	New	+$96.6K	﹤0.01%	2660
2017 Q3	–	Sell	-390	Closed	-$68K	–	2063
2017 Q2	$68K	Buy	+390	New	+$55.5K	﹤0.01%	1507
2015 Q2	–	Sell	-446	Closed	-$66K	–	2120
2015 Q1	$66K	Buy	+446	New	+$67.9K	﹤0.01%	1719
2014 Q3	–	Sell	-553	Closed	-$72K	–	1926
2014 Q2	$72K	Buy	+553	New	+$70.2K	﹤0.01%	1370

Other funds holding SRGA

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

WWP

WR Wealth Planners Columbia, Missouri $311M AUM 18.22% 1-Year Est. Return

Cubist Systematic Strategies's SRGA Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 48,756 shares — an estimated $8.92K sold.

Cubist Systematic Strategies first reported a position in SRGA in Q2 2014 and held it in 6 quarters. The position peaked at $91K in Q1 2021. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

Cubist Systematic Strategies reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 48,756 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $8.92K.
Cubist Systematic Strategies first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2014 and held it in 6 quarters.
Cubist Systematic Strategies's Surgalign Holdings, Inc. Common Stock position peaked at $91K in Q1 2021.
4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.